Ads
related to: acute myeloid leukemia treatment- BENDEKA® Therapy
Learn About An Infusion Therapy
Therapy Plan For Your Patients.
- Dosing & Administration
Get More Information On BENDEKA®
Approved Indications.
- About BENDEKA®
Get Information About BENDEKA®
For Your Patients & Practice.
- BENDEKA® Treatment
Find Important Information
On BENDEKA® Treatment Options.
- Codes & Reimbursement
Find BENDEKA® Billing Codes.
Learn About Patient Reimbursement.
- Support For Patients
Learn About BENDEKA®
Patient Assistance Program.
- BENDEKA® Therapy
Search results
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 5 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 4 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 1 day agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 5 days agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
InvestorPlace· 4 days agoOne of the hottest investment trends to jump on at the moment is machine learning stocks to buy. Along the way, machines will learn from historical data, identify patterns, and make logical ...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoToday, we are providing updates for our highly differentiated LSD1 inhibitor the XS74539, or 539, which continues its progression towards a Phase 1 clinical trial in acute ...
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 2 days agoEquities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...
Ads
related to: acute myeloid leukemia treatment